Gotham Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-61,292
Closed -$1.14M 1283
2022
Q1
$1.14M Buy
+61,292
New +$1.1M 0.04% 523

Other funds holding OCDX

Gotham Asset Management's OCDX Position: Q2 2022 in Review

Gotham Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 61,292 shares — an estimated $1.14M sold.

Gotham Asset Management first reported a position in OCDX in Q1 2022 and held it in 1 quarter. The position peaked at $1.14M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Gotham Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Gotham Asset Management sold 61,292 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $1.14M.
  • Gotham Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2022 and held it in 1 quarter.
  • Gotham Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.14M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Gotham Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.